Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Organon & Co. Common Stock
(NY:
OGN
)
7.140
UNCHANGED
Official Closing Price
Updated: 7:00 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,325,843
Open
7.140
Bid (Size)
7.080 (800)
Ask (Size)
7.150 (200)
Prev. Close
7.140
Today's Range
7.043 - 7.190
52wk Range
6.180 - 17.23
Shares Outstanding
259,965,579
Dividend Yield
1.12%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Value Stocks with Questionable Fundamentals
December 04, 2025
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...
Via
StockStory
3 Cash-Producing Stocks We Find Risky
December 03, 2025
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...
Via
StockStory
Performance
YTD
-52.3%
-52.3%
1 Month
+6.4%
+6.4%
3 Month
-31.8%
-31.8%
6 Month
-26.8%
-26.8%
1 Year
-52.8%
-52.8%
More News
Read More
Organon (OGN): Buy, Sell, or Hold Post Q3 Earnings?
November 30, 2025
Via
StockStory
Topics
Stocks
Q3 Rundown: Organon (NYSE:OGN) Vs Other Branded Pharmaceuticals Stocks
November 25, 2025
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Earnings Scheduled For November 10, 2025
↗
November 10, 2025
Via
Benzinga
A Look at Organon's Upcoming Earnings Report
↗
November 07, 2025
Via
Benzinga
Organon To Present at the Piper Sandler 37th Annual Healthcare Conference
November 25, 2025
From
Organon & Co.
Via
Business Wire
Henlius and Organon Announce US FDA Approval of POHERDY® (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
November 17, 2025
From
Organon & Co.
Via
Business Wire
The 5 Most Interesting Analyst Questions From Organon’s Q3 Earnings Call
November 17, 2025
Via
StockStory
Topics
Earnings
Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN
November 14, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
Organon (OGN) Stock Trades Down, Here Is Why
November 11, 2025
Via
StockStory
Topics
Artificial Intelligence
Initial Public Offering
Supply Chain
Organon Analysts Cut Their Forecasts Following Q3 Results
↗
November 11, 2025
Via
Benzinga
OGN Q3 2025 Deep Dive: Leadership Changes, Portfolio Shifts, and Guidance Recalibration
November 11, 2025
Via
StockStory
Organon Cuts 2025 Sales Outlook Despite Earnings Beat
↗
November 10, 2025
Via
Benzinga
Organon (NYSE:OGN) Posts Better-Than-Expected Sales In Q3
November 10, 2025
Via
StockStory
Tech Rallies, Palantir Jumps 6% As Shutdown End Looms: What's Moving Markets Monday?
↗
November 10, 2025
Via
Benzinga
Organon Reports Results for the Third Quarter Ended September 30, 2025
November 10, 2025
From
Organon & Co.
Via
Business Wire
Organon (OGN) Reports Earnings Tomorrow: What To Expect
November 08, 2025
Via
StockStory
Topics
Artificial Intelligence
New Data Show Early and Consistent Response to VTAMA® (tapinarof) Cream, 1%, in Children Aged 2+ with Atopic Dermatitis, Including Those With Associated Comorbidities
November 08, 2025
From
Organon & Co.
Via
Business Wire
Organon Announces Agreement to Divest its JADA® System for Up to $465 Million to Laborie
November 07, 2025
From
Organon & Co.
Via
Business Wire
Organon To Report Third Quarter 2025 Results and Host Conference Call on November 10, 2025
November 06, 2025
From
Organon & Co.
Via
Business Wire
2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid
November 02, 2025
Via
StockStory
1 of Wall Street’s Favorite Stock with Impressive Fundamentals and 2 We Ignore
October 29, 2025
Via
StockStory
Why Organon (OGN) Stock Is Down Today
October 28, 2025
Via
StockStory
Topics
Economy
Government
Initial Public Offering
Organon Investigation Initiated By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Claims On Behalf of Investors of Organon & Co. - OGN
October 28, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
Frequently Asked Questions
Is Organon & Co. Common Stock publicly traded?
Yes, Organon & Co. Common Stock is publicly traded.
What exchange does Organon & Co. Common Stock trade on?
Organon & Co. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Organon & Co. Common Stock?
The ticker symbol for Organon & Co. Common Stock is OGN on the New York Stock Exchange
What is the current price of Organon & Co. Common Stock?
The current price of Organon & Co. Common Stock is 7.140
When was Organon & Co. Common Stock last traded?
The last trade of Organon & Co. Common Stock was at 12/05/25 07:00 PM ET
What is the market capitalization of Organon & Co. Common Stock?
The market capitalization of Organon & Co. Common Stock is 1.86B
How many shares of Organon & Co. Common Stock are outstanding?
Organon & Co. Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.